Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise
beta
Latest Financials
Filings:
By Category
By Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
Company Exhibits:
Indentures
Material Contracts & Credit Agreements
Plans of Reorganization
Articles and Bylaws
Underwriting Agreements
SEC Edgar
RXO, Inc.
SIC 4700 · Transportation Services
Notes
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
RXO, Inc.
SIC 4700 · Transportation Services
Notes
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
RXO, Inc.
SIC 4700 · Transportation Services
Notes
Support
about
terms
$
RXO
RXO, Inc.
CIK:
0001929561
|
SEC Filings
Income Statement
Cash Flow
Balance Sheet
v3.26.1
Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Millions
3 Months Ended
6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Income Statement [Abstract]
Revenue
$ 1,774
$ 1,419
$ 3,199
$ 2,852
Cost of transportation and services (exclusive of depreciation and amortization)
1,472
1,118
2,643
2,271
Direct operating expense (exclusive of depreciation and amortization)
53
47
103
95
Sales, general and administrative expense
211
214
408
424
Depreciation and amortization expense
26
30
52
62
Transaction and integration costs
4
7
6
13
Restructuring costs
7
3
14
17
Operating income (loss)
1
0
(27)
(30)
Other expense
0
2
1
2
Debt extinguishment loss
0
0
11
0
Interest expense, net
9
8
18
17
Loss before income taxes
(8)
(10)
(57)
(49)
Income tax provision (benefit)
1
(1)
(12)
(9)
Net loss
$ (9)
$ (9)
$ (45)
$ (40)
Loss per share
Earnings per share, basic (in dollars per share)
$ (0.05)
$ (0.05)
$ (0.27)
$ (0.24)
Earnings per share, diluted (in dollars per share)
$ (0.05)
$ (0.05)
$ (0.27)
$ (0.24)
Weighted-average common shares outstanding
Basic weighted-average common shares outstanding (in shares)
169,646
168,525
169,377
168,275
Diluted weighted-average common shares outstanding (in shares)
169,646
168,525
169,377
168,275
v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Millions
3 Months Ended
6 Months Ended
9 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Sep. 30, 2025
Operating activities
Net loss
$ (9)
$ (9)
$ (45)
$ (40)
Adjustments to reconcile net loss to net cash from operating activities
Depreciation and amortization expense
26
30
52
62
Stock compensation expense
14
14
Deferred tax benefit
(15)
(13)
Impairment of operating lease assets
2
4
Debt extinguishment loss
0
0
11
0
$ 0
Other
5
6
Changes in assets and liabilities
Accounts receivable
(223)
159
Other current assets and other long-term assets
(26)
(7)
Accounts payable
179
(93)
Accrued expenses, other current liabilities and other long-term liabilities
(1)
(71)
Net cash provided by (used in) operating activities
(47)
21
Investing activities
Payment for purchases of property and equipment
(29)
(29)
Proceeds from sale of property and equipment
0
1
Business acquisition, net of cash acquired
0
(10)
Other
0
(5)
Net cash used in investing activities
(29)
(43)
Financing activities
Proceeds from borrowings on revolving credit facilities
656
261
Repayment of borrowings on revolving credit facilities
(607)
(227)
Proceeds from issuance of debt
400
0
Repurchase of debt
(362)
0
Repayment of debt and finance leases
(1)
(1)
Payment for debt issuance costs
(9)
0
Payment for equity issuance costs
0
(1)
Payment for tax withholdings related to vesting of stock compensation awards
(3)
(18)
Other
0
(10)
Net cash provided by financing activities
74
4
Effect of exchange rates on cash, cash equivalents and restricted cash
0
2
Net decrease in cash, cash equivalents and restricted cash
(2)
(16)
Cash, cash equivalents, and restricted cash, beginning of period
18
35
$ 35
Cash, cash equivalents, and restricted cash, end of period
$ 16
$ 19
16
19
Supplemental disclosure of cash flow information:
Leased assets obtained in exchange for new operating lease liabilities
19
22
Cash paid for income taxes, net
5
4
Cash paid for interest, net
11
16
Purchases of property and equipment in accounts payable, accrued expenses and other liabilities
$ 2
$ 10
v3.26.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Millions
Jun. 30, 2026
Dec. 31, 2025
Current assets
Cash and cash equivalents
$ 15
$ 17
Accounts receivable, net of $15 and $16 in allowances, respectively
1,444
1,226
Other current assets
97
74
Total current assets
1,556
1,317
Property and equipment, net of $412 and $381 in accumulated depreciation, respectively
126
134
Operating lease assets
205
238
Goodwill
1,111
1,111
Identifiable intangible assets, net of $184 and $164 in accumulated amortization, respectively
432
453
Other long-term assets
29
24
Total long-term assets
1,903
1,960
Total assets
3,459
3,277
Current liabilities
Accounts payable
713
539
Accrued expenses
404
397
Short-term debt and current maturities of long-term debt
36
17
Short-term operating lease liabilities
66
75
Other current liabilities
8
10
Total current liabilities
1,227
1,038
Long-term debt and obligations under finance leases
459
387
Deferred tax liabilities
35
51
Long-term operating lease liabilities
167
191
Other long-term liabilities
65
69
Total long-term liabilities
726
698
Commitments and Contingencies (Note 9)
Equity
Preferred stock, $0.01 par value; 10,000 shares authorized; 0 shares issued and outstanding as of June 30, 2026 and December 31, 2025
0
0
Common stock, $0.01 par value; 300,000 shares authorized; 164,920 and 164,160 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively
2
2
Additional paid-in capital
1,940
1,929
Accumulated deficit
(429)
(384)
Accumulated other comprehensive loss
(7)
(6)
Total equity
1,506
1,541
Total liabilities and equity
$ 3,459
$ 3,277
Common stock, shares outstanding (in shares)
164,920,000
164,160,000
Common stock, shares issued (in shares)
164,920,000
164,160,000